Integris Medtech files ₹4,000 crore IPO with SEBI
Integris Medtech just filed for an IPO with SEBI, with people familiar with the matter estimating the issue size at ₹3,500-4,000 crore.
The plan includes a fresh share issue of ₹925 crore and an offer for sale of 2.16 crore shares by promoters Evercure Holdings, Gurmit Singh Chugh, and Punita Sharma.
Most of the money raised will go toward paying off group debt, with the rest set aside for general business needs.
There's also a chance of a pre-IPO placement worth up to ₹185 crore.
The company is backed by Everstone Capital Asia
Co-founded by Chugh and Sharma and backed by Everstone Capital Asia, Integris Medtech makes cardiovascular and clinical diagnostic devices.
Their manufacturing happens in India, Germany, and the Netherlands—and their products reach over 65 countries.
The company's financials
In FY25 (the current financial year), total income jumped 23.85% to ₹1,959.6 crore.
The company swung back to profit too—netting ₹70.6 crore after posting a loss last year.